Scott Mendel, Chief Operating Officer at GenMark Diagnostics, Inc. (GNMK), sold 5,206 shares at $5.43 ($28K) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Tax-driven sale ($28k) by Chief Operating Officer — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |